Sanofi (SNY) Enterprise Value (2016 - 2024)
Historic Enterprise Value for Sanofi (SNY) over the last 17 years, with Q3 2025 value amounting to -$10.4 billion.
- Sanofi's Enterprise Value fell 2165.33% to -$10.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.4 billion, marking a year-over-year decrease of 2165.33%. This contributed to the annual value of -$8.9 billion for FY2024, which is 478.92% up from last year.
- As of Q3 2025, Sanofi's Enterprise Value stood at -$10.4 billion, which was down 2165.33% from -$17.1 billion recorded in Q2 2025.
- In the past 5 years, Sanofi's Enterprise Value ranged from a high of -$6.9 billion in Q1 2023 and a low of -$17.1 billion during Q2 2025
- In the last 5 years, Sanofi's Enterprise Value had a median value of -$10.4 billion in 2025 and averaged -$10.7 billion.
- Per our database at Business Quant, Sanofi's Enterprise Value soared by 3833.53% in 2023 and then plummeted by 8244.1% in 2025.
- Over the past 5 years, Sanofi's Enterprise Value (Quarter) stood at -$11.5 billion in 2021, then decreased by 9.72% to -$12.6 billion in 2022, then rose by 26.04% to -$9.3 billion in 2023, then increased by 4.28% to -$8.9 billion in 2024, then dropped by 16.55% to -$10.4 billion in 2025.
- Its Enterprise Value was -$10.4 billion in Q3 2025, compared to -$17.1 billion in Q2 2025 and -$9.2 billion in Q1 2025.